DIVISION OF NEURODEGENERATIVE DISORDERS
ST. BONIFACE HOSPITAL ALBRECHTSEN RESEARCH CENTRE
University of Manitoba
PhDs in Neuroscience/Neuropharmacology – CIHR funded (5 years)
The St Boniface Hospital Albrechtsen Research Centre offers a vibrant and interactive research environment for graduate studies in the molecular cell biology of neurodegenerative diseases. Three PhD positions are available in the Pharmacology Graduate Program in the Division of Neurodegenerative Disorders:
Position 1: Role of the calcium channel, TRPM3, in controlling axonal outgrowth and repair. (PI: Dr. P. Fernyhough)
Position 2: Mechanism of muscarinic receptor regulation of mitochondrial function in axons of adult neurons. (PI: Dr. P. Fernyhough)
Position 3: Mitochondrial Dysfunction in Alzheimer’s Disease. (PI: Dr. B. Albensi)
Potential applicants for positions 1&2 can derive background information from Calcutt et al (2017) J.Clin.Invest. 127:608. For position 3, applicants should refer to Cadonic & Albensi (2016) Mol Neurobiol 53:6078 and Djordjevic et al. (2017) Neuroscience 361:81.
Students with an undergraduate and/or masters background in biology, cell biology, biochemistry, neuroscience and/or pharmacology/physiology are encouraged to apply. Stipends of CA$20,000 or more are available commensurate with level of experience.
Interested students should send a CV to Dr. Paul Fernyhough (e-mail: firstname.lastname@example.org) or Dr. Benedict C. Albensi (email: email@example.com).
Posting end date 2019/03/31